C[C@]1(C=O)C2CC[C@@]3(C)O[C@@]14C(=O)c1ccc(O)cc1C(=O)C4=CC23
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?